Telbivudine for the treatment of chronic hepatitis B in HBeAg-positive patients in China: a health economic analysis-Reference-Cited by-同舟云学术

Telbivudine for the treatment of chronic hepatitis B in HBeAg-positive patients in China: a health economic analysis

Published:2016-10-05 Issue:1 Volume:5 Page:
ISSN:2193-1801
Container-title:SpringerPlus
language:en
Short-container-title:SpringerPlus

Author:

Banerjee S.,Gunda P.,Drake R. F.,Hamed K.^ORCID

Funder

Novartis Pharmaceuticals Corporation (US)

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://link.springer.com/content/pdf/10.1186/s40064-016-3404-x.pdf

Reference48 articles.

1. Almeida AM, Silva AL, Brandao CM et al (2012) Cost-effectiveness of nucleoside/nucleotide analogues in chronic hepatitis B. Rev Saude Publica 46(6):942–949

2. Biazar T, Yahyapour Y, Hasanjani Roushan MR et al (2015) Relationship between hepatitis B DNA viral load in the liver and its histology in patients with chronic hepatitis B. Casp J Intern Med 6(4):209–212

3. Blumenthal D, Hsiao W (2015) Lessons from the East–China’s rapidly evolving health care system. N Engl J Med 372(14):1281–1285

4. Chan TM (2010) Hepatitis B and Renal Disease. Curr Hepat Rep 9(2):99–105

5. Chang TT (2009) On-treatment monitoring of HBV DNA levels: predicting response and resistance to oral antiviral therapy at week 24 versus week 48. Hepatol Int 3(Suppl 1):16–23

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-vaccination anti-HBs testing among healthcare workers: More economical than post-exposure management for Hepatitis B;Revista Latino-Americana de Enfermagem;2020

2. Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature Review;PharmacoEconomics - Open;2019-08-19

3. Baseline serum miR‑125b levels predict virologic response to nucleos(t)ide analogue treatment in patients with HBeAg‑positive chronic hepatitis B;Experimental and Therapeutic Medicine;2018-09-03

4. Chronic Hepatitis B Treatment: Current Perspectives on Telbivudine;Istanbul Medical Journal;2017-12-21

5. Kushenin combined with adefovir dipivoxil affects the HBV-DNA load in serum, immune functions and liver functions of patients with chronic hepatitis B;Experimental and Therapeutic Medicine;2017-10-06